Related references
Note: Only part of the references are listed.Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial
Ally Olotu et al.
LANCET INFECTIOUS DISEASES (2011)
Identification of Hot Spots of Malaria Transmission for Targeted Malaria Control
Teun Bousema et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray
Peter D. Crompton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The Relationship between Anti-merozoite Antibodies and Incidence of Plasmodium falciparum Malaria: A Systematic Review and Meta-analysis
Freya J. I. Fowkes et al.
PLOS MEDICINE (2010)
Analysis of Immunity to Febrile Malaria in Children That Distinguishes Immunity from Lack of Exposure
Philip Bejon et al.
INFECTION AND IMMUNITY (2009)
Long-Term Safety and Efficacy of the RTS,S/AS02A Malaria Vaccine in Mozambican Children
Jahit Sacarlal et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Characterization of a protective Escherichia coli-expressed Plasmodium falciparum merozoite surface protein 3 indicates a non-linear, multi-domain structure
Chiawei W. Tsai et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2009)
Immunological mechanisms underlying protection mediated by RTS,S: a review of the available data
Vasee S. Moorthy et al.
MALARIA JOURNAL (2009)
Insights into Long-Lasting Protection Induced by RTS,S/AS02A Malaria Vaccine: Further Results from a Phase IIb Trial in Mozambican Children
Caterina Guinovart et al.
PLOS ONE (2009)
Interactions between Age and ITN Use Determine the Risk of Febrile Malaria in Children
Philip Bejon et al.
PLOS ONE (2009)
Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria
Faith H. A. Osier et al.
INFECTION AND IMMUNITY (2008)
Spatial variation of malaria incidence in young children from a geographically homogeneous area with high endemicity
Benno Kreuels et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Dried blood spots as a source of anti-malarial antibodies for epidemiological studies
Patrick H. Corran et al.
MALARIA JOURNAL (2008)
Immunity to malaria: more questions than answers
Jean Langhorne et al.
NATURE IMMUNOLOGY (2008)
Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of Age
Philip Bejon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Acquisition of Growth-Inhibitory Antibodies against Blood-Stage Plasmodium falciparum
Fiona J. McCallum et al.
PLOS ONE (2008)
Antibody-Mediated Growth Inhibition of Plasmodium falciparum: Relationship to Age and Protection from Parasitemia in Kenyan Children and Adults
Arlene E. Dent et al.
PLOS ONE (2008)
Recent insights into humoral and cellular immune responses against malaria
James G. Beeson et al.
TRENDS IN PARASITOLOGY (2008)
The limits and intensity of Plasmodium falciparum transmission:: Implications for malaria control and elimination worldwide
Carlos A. Guerra et al.
PLOS MEDICINE (2008)
Humoral responses to Plasmodium falciparum blood-stage antigens and association with incidence of clinical malaria in children living in an area of seasonal malaria transmission in Burkina Faso, West Africa
Issa Nebie et al.
INFECTION AND IMMUNITY (2008)
The decline in paediatric malaria admissions on the coast of Kenya
Emelda A. Okiro et al.
MALARIA JOURNAL (2007)
Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar
Achuyt Bhattarai et al.
PLOS MEDICINE (2007)
Malaria-specific antibody responses and parasite persistence after infection of mice with Plasmodium chabaudi chabaudi
A. H. Achtman et al.
PARASITE IMMUNOLOGY (2007)
Profiling the antibody immune response against blood stage malaria vaccine candidates
Julian C. Gray et al.
CLINICAL CHEMISTRY (2007)
Dynamics of polymorphism in a malaria vaccine antigen at a vaccine-testing site in Mali
Shannon L. Takala et al.
PLOS MEDICINE (2007)
Space-time clustering of childhood malaria at the household level: a dynamic cohort in a Mali village
Jean Gaudart et al.
BMC PUBLIC HEALTH (2006)
Evaluation of three Pichia pastoris-expressed Plasmodium falciparum merozoite proteins as a combination vaccine against infection with blood-stage parasites
DM Zhang et al.
INFECTION AND IMMUNITY (2005)
Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure
CJ Drakeley et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
A space-time permutation scan statistic for disease outbreak detection
M Kulldorff et al.
PLOS MEDICINE (2005)
Calculation of liver-to-blood inocula, parasite growth rates, and preerythrocytic vaccine efficacy, from serial quantitative polymerase chain reaction studies of volunteers challenged with malaria sporozoites
P Bejon et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
The fine specificity, but not the invasion inhibitory activity, of 19-kilodalton merozoite surface protein 1-specific antibodies is associated with resistance to malarial parasitemia in a cross-sectional survey in the Gambia
PH Corran et al.
INFECTION AND IMMUNITY (2004)
Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children:: randomised controlled trial
PL Alonso et al.
LANCET (2004)
Development and pre-clinical analysis of a Plasmodium falciparum Merozoite Surface Protein-142 malaria vaccine
E Angov et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2003)
The human immune response to Plasmodium falciparum includes both antibodies that inhibit merozoite surface protein 1 secondary processing and blocking antibodies
RI Nwuba et al.
INFECTION AND IMMUNITY (2002)
Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum
DJ Pombo et al.
LANCET (2002)
Purification, characterization, and immunogenicity of the refolded ectodomain of the Plasmodium falciparum apical membrane antigen 1 expressed in Escherichia coli
S Dutta et al.
INFECTION AND IMMUNITY (2002)
Share Paper
